Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform
TORONTO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical...
Day: September 14, 2023
23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program
23andMe will offer its Health + Ancestry Service at no cost for up to 1,000 eligible* participants who are 18...
Montauk Brewing Expands Distribution Beyond the Northeast
Montauk’s Easy-Drinking and Best-Selling Craft Beers Are Now Available at Major Retailers, Restaurants and Bars Across GeorgiaNEW YORK, Sept. 14,...
Tonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700 in Preclinical Colorectal Cancer Models at the Seventh International Cancer Immunotherapy Conference 2023
CHATHAM, N.J., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...
Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943
Phase 1 trial enrolling patients with relapsed/refractory AML, MDS and B-cell ALLPALO ALTO, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) --...
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
First Wave to develop and repurpose Capeserod for gastrointestinal (GI) indications based on AI-empowered analyses, expanding the company’s GI-focused pipelineBOCA...
Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD
Bionomics has collaborated with MSD to identify novel α7 nAChR PAMs suitable for the treatment of cognitive disorders like Alzheimer’s...
Mangoceuticals Brand MangoRx Announced as Raindance Film Festival’s Headline Sponsor
The London-Based International Film Festival Will Feature the MangoRx Short Film Competition Focused on Mental Health and Erectile Dysfunction Dallas,...
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
The Company’s development pipeline now includes three projects with UCLALEHI, Utah, Sept. 14, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a...
AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders
New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership...
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
Intravacc - intranasally administered OMV Key mode of action of intranasally administered OMVs. Mucosal route induces both localized and systemic...
Sequana Medical announces H1 2023 results and provides business update
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION14 September 2023, 07:00 CEST alfapump® – strong pivotal POSEIDON data presented at leading international...
BioSenic reaches agreement on binding term sheets with main creditors to restructure past financial debts
INSIDE INFORMATION New binding term sheets have been formulated upon for the replacement of the Monument and Patronale bonds and...
Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi™ (Sovateltide) in India
Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to...
CBD of Denver Inc. Announces Luxora Has Signed 4 Letters of Intent to Build and Manage 4 Cannabis Clubs in Germany
Denver, Colorado--(Newsfile Corp. - September 14, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD), is pleased to announce that...
Awakn Life Sciences Provides Corporate Update
Announces Closing of Third Tranche of Private PlacementToronto, Ontario--(Newsfile Corp. - September 14, 2023) - Awakn Life Sciences Corp. (NEO:...
Audax Strategic Capital and Sunstone Partners Infuse Capital into EverService to Support Organic Growth and Continue M&A Pursuits
New funding facilitates 8th add-on acquisition by EverService, a majority-owned portfolio company of Sunstone Partners since 2018SAN MATEO, Calif. &...
Neoss® Group launches NeoTell™ a new device to measure implant stability.
ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership...